- Home
- EBC vs PTCT Comparison
EBC vs PTCT Comparison
Compare EBC & PTCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EBC
- PTCT
- Stock Information
- Founded
- EBC 1818
- PTCT 1998
- Country
- EBC United States
- PTCT United States
- Employees
- EBC N/A
- PTCT N/A
- Industry
- EBC Accident &Health Insurance
- PTCT Biotechnology: Pharmaceutical Preparations
- Sector
- EBC Finance
- PTCT Health Care
- Exchange
- EBC Nasdaq
- PTCT Nasdaq
- Market Cap
- EBC 3.5B
- PTCT 3.9B
- IPO Year
- EBC 2020
- PTCT 2013
- Fundamental
- Price
- EBC $16.22
- PTCT $46.39
- Analyst Decision
- EBC Buy
- PTCT Buy
- Analyst Count
- EBC 2
- PTCT 14
- Target Price
- EBC $19.25
- PTCT $63.57
- AVG Volume (30 Days)
- EBC 1.6M
- PTCT 899.2K
- Earning Date
- EBC 07-24-2025
- PTCT 08-07-2025
- Dividend Yield
- EBC 3.21%
- PTCT N/A
- EPS Growth
- EBC N/A
- PTCT N/A
- EPS
- EBC N/A
- PTCT 7.51
- Revenue
- EBC $457,519,000.00
- PTCT $1,772,758,000.00
- Revenue This Year
- EBC $25.36
- PTCT $121.37
- Revenue Next Year
- EBC $27.80
- PTCT N/A
- P/E Ratio
- EBC N/A
- PTCT $6.20
- Revenue Growth
- EBC N/A
- PTCT 91.12
- 52 Week Low
- EBC $13.51
- PTCT $29.02
- 52 Week High
- EBC $19.40
- PTCT $58.38
- Technical
- Relative Strength Index (RSI)
- EBC 61.36
- PTCT 38.80
- Support Level
- EBC $15.38
- PTCT $47.28
- Resistance Level
- EBC $16.32
- PTCT $49.45
- Average True Range (ATR)
- EBC 0.32
- PTCT 1.56
- MACD
- EBC 0.02
- PTCT -0.23
- Stochastic Oscillator
- EBC 89.36
- PTCT 10.84
About EBC Eastern Bankshares Inc.
Eastern Bankshares Inc is a commercial bank that caters its products and services to retail, commercial, and small business customers. Its diversified products and services include lending, deposit, wealth management, and insurance products. The company has one operating segment; Banking business which offers a range of banking lending, savings, and small business offerings, and its wealth management and trust operations.
About PTCT PTC Therapeutics Inc.
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.